Document is current
Any future updates will be listed below
-
Authors
Chaung, Wayne
Ma, Gaifeng
Jacob, Asha
Brenner, Max
Wang, Ping
-
Funding
Funding for this research was provided by:
National Institutes of Health (R44 AI114218, UO1 AI133655)
- License Information
-
More Information
Article History
Received: 20 July 2023
Accepted: 8 December 2023
First Online: 13 December 2023
Competing interests
: PW is the inventor of patents entitled “<i>Treatment and prevention of radiation injury using MFG-E8</i>” (US/2017/9669070B2) and “<i>Prevention and treatment of inflammation and organ injury after ischemia/reperfusion using MFG-E8</i>” (WO/2009/064448). PW is a co-founder of TheraSource LLC, which has an exclusive option to license the relevant technology. WC, GM and MB are part-time employees of TheraSource LLC. AJ declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
